Discover and read the best of Twitter Threads about #olaparib
Most recents (2)
@TumorBoardTues @MPishvaian @HeekeMd 1/14
#TumorBoardTuesday #bcsm
Join us to discuss a personalized approach to BC tx in pts with ER+ #bcsm
A 53 yo👩 with HR+, HER2- IDC, very large grade 3 tumor, multiple + nodes
@OncoAlert @BurrisSkip @KalinskyKevin @matteolambe @Dr_RShatsky @maryam_lustberg @drsarahsam
#TumorBoardTuesday #bcsm
Join us to discuss a personalized approach to BC tx in pts with ER+ #bcsm
A 53 yo👩 with HR+, HER2- IDC, very large grade 3 tumor, multiple + nodes
@OncoAlert @BurrisSkip @KalinskyKevin @matteolambe @Dr_RShatsky @maryam_lustberg @drsarahsam
@TumorBoardTues @MPishvaian @HeekeMd @OncoAlert @BurrisSkip @KalinskyKevin @matteolambe @Dr_RShatsky @maryam_lustberg @drsarahsam 2/14
#TumorBoardTuesday #bcsm
She has 3👨👦👦,🚭, no comorbidities
FMHx: maternal aunt had gastric cancer & paternal cousin had CRC
Tx with neoadjuvant AC ----> T with some response but significant residual disease. 😥
What info would you need to treat this patient?
#TumorBoardTuesday #bcsm
She has 3👨👦👦,🚭, no comorbidities
FMHx: maternal aunt had gastric cancer & paternal cousin had CRC
Tx with neoadjuvant AC ----> T with some response but significant residual disease. 😥
What info would you need to treat this patient?
@TumorBoardTues @MPishvaian @HeekeMd @OncoAlert @BurrisSkip @KalinskyKevin @matteolambe @Dr_RShatsky @maryam_lustberg @drsarahsam 3/14 #TumorBoardTuesday #bcsm Mini-Tweetorial 1
Only 12% of ♀️ in general population develop BC, BUT 55-65% of ♀️ with inherited BRCA1 can develop BC!
Only 12% of ♀️ in general population develop BC, BUT 55-65% of ♀️ with inherited BRCA1 can develop BC!
Folks! We return for #HOTrainees with the exciting #Day2 @myESMO #ESMO20 and some more #practice relevant studies in #breastcancer #ProstateCancer #lungcancer #GI, so sit back, relax and lets go through some data (#HO #trainee-style!) Shout out to @peters_solange @OncoAlert
1. #BreastCancer: We have #monarchE and #IMPassion031 hoping to hear from experts @ErikaHamilton9 @NicoleKuderer @DrSGraff @matteolambe @tmprowell @GeorgeSledge51 @VukovicPetra for more insights- please link to your discussions here for #trainees:
1. A) #monarchE: use of #abemiciclib in HR+, HER2-,high risk #EBC in addition to endocrine therapy.
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
Current #SOC: adjuvant ET (5-10 years)
#monarchE: #Abemaciclib + ET iDFS HR 0.747, here's a great summary by @ErikaHamilton9 for @OncoAlert :
